Unravelling multiple ligand-activation binding sites using RASSL receptors

被引:15
作者
Pauwels, PJ [1 ]
机构
[1] Ctr Immunol Pierre Fabre, F-74164 St Julein En Genevois, France
关键词
D O I
10.1016/j.tips.2003.08.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The principle of receptors activated solely by synthetic ligands (RASSLs) as discovered for chimeric opioid peptide receptors has been extended to point-mutated 5-HT4 receptors and alpha(2A)-adrenoceptors. On binding to these RASSLs, which are insensitive to their native ligands, synthetic ligands exhibit either similar, lower or higher agonist efficacy than they exhibit following binding to wild-type receptors. Furthermore, several antagonists demonstrate potent agonist responses following binding to RASSLs. The recent development of new RASSLs raises the potential for in vivo stimulation of multiple signalling pathways with ligands that have no agonist potential at wild-type receptors, which could improve our understanding of receptor signalling.
引用
收藏
页码:504 / 507
页数:4
相关论文
共 14 条
[1]   A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL) [J].
Claeysen, S ;
Joubert, L ;
Sebben, M ;
Bockaert, J ;
Dumuis, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :699-702
[2]   Controlling signaling with a specifically designed Gi-coupled receptor [J].
Coward, P ;
Wada, HG ;
Falk, MS ;
Chan, SDH ;
Meng, F ;
Akil, H ;
Conklin, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :352-357
[3]   PARTIAL AGONISTS, FULL AGONISTS, ANTAGONISTS - DILEMMAS OF DEFINITION [J].
HOYER, D ;
BODDEKE, HWGM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (07) :270-275
[4]   A 5-HT4 receptor transmembrane network implicated in the activity of inverse agonists but not agonists [J].
Joubert, L ;
Claeysen, S ;
Sebben, M ;
Bessis, AS ;
Clark, RD ;
Martin, RS ;
Bockaert, J ;
Dumuis, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :25502-25511
[5]   Inverse, protean, and ligand-selective agonism: matters of receptor conformation [J].
Kenakin, T .
FASEB JOURNAL, 2001, 15 (03) :598-611
[6]   Heterogeneous ligand-mediated Ca++ responses at wt and mutant α2A-adrenoceptors suggest multiple ligand activation binding sites at the α2A-adrenoceptor [J].
Pauwels, PJ ;
Colpaert, FC .
NEUROPHARMACOLOGY, 2000, 39 (11) :2101-2111
[7]   Disparate ligand-mediated Ca2+ responses by wild-type, mutant Ser200Ala and Ser204Ala α2A-adrenoceptor:: Gα15 fusion proteins:: evidence for multiple ligand-activation binding sites [J].
Pauwels, PJ ;
Colpaert, FC .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (07) :1505-1512
[8]   Diverse signalling by 5-hydroxytryptamine (5-HT) receptors [J].
Pauwels, PJ .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (12) :1743-1750
[9]   Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice [J].
Redfern, CH ;
Coward, P ;
Degtyarev, MY ;
Lee, EK ;
Kwa, AT ;
Hennighausen, L ;
Bujard, H ;
Fishman, GI ;
Conklin, BR .
NATURE BIOTECHNOLOGY, 1999, 17 (02) :165-169
[10]   Three-dimensional models of α2A-adrenergic receptor complexes provide a structural explanation for ligand binding [J].
Salminen, T ;
Varis, M ;
Nyrönen, T ;
Pihlavisto, M ;
Hoffrén, AM ;
Lönnberg, T ;
Marjamäki, A ;
Frang, H ;
Savola, JM ;
Scheinin, M ;
Johnson, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23405-23413